drugset / Trial / NCT00230607
Study of the Effects of Fabrazyme Treatment on Lactation and Infants
NaSingle-groupOpen-labelTreatment
Summary
The study was planned for up to 2 years (24 months). Planned full participation for both mother and infant was 24 months, planned full participation of mother and development of infant was 24 months, while planned full participation of mother and no infant participation was 6 months.
Timeline
- Start
- 2006-05-28
- Primary completion
- 2024-02-09
- Completion
- 2024-02-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | agalsidase beta | Protein / enzyme biologic | — | Intravenous |